CRSP
Price
$39.30
Change
+$5.04 (+14.71%)
Updated
Apr 11 closing price
Capitalization
3.37B
29 days until earnings call
KYTX
Price
$2.06
Change
+$0.19 (+10.16%)
Updated
Apr 11 closing price
Capitalization
89.02M
37 days until earnings call
Ad is loading...

CRSP vs KYTX

Header iconCRSP vs KYTX Comparison
Open Charts CRSP vs KYTXBanner chart's image
CRISPR Therapeutics AG
Price$39.30
Change+$5.04 (+14.71%)
Volume$3.65M
Capitalization3.37B
Kyverna Therapeutics
Price$2.06
Change+$0.19 (+10.16%)
Volume$167.49K
Capitalization89.02M
CRSP vs KYTX Comparison Chart
Loading...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRSP vs. KYTX commentary
Apr 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRSP is a Hold and KYTX is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 13, 2025
Stock price -- (CRSP: $39.30 vs. KYTX: $2.06)
Brand notoriety: CRSP and KYTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRSP: 153% vs. KYTX: 56%
Market capitalization -- CRSP: $3.37B vs. KYTX: $89.02M
CRSP [@Biotechnology] is valued at $3.37B. KYTX’s [@Biotechnology] market capitalization is $89.02M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.66B to $0. The average market capitalization across the [@Biotechnology] industry is $1.98B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRSP’s FA Score shows that 0 FA rating(s) are green whileKYTX’s FA Score has 0 green FA rating(s).

  • CRSP’s FA Score: 0 green, 5 red.
  • KYTX’s FA Score: 0 green, 5 red.
According to our system of comparison, both CRSP and KYTX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRSP’s TA Score shows that 6 TA indicator(s) are bullish while KYTX’s TA Score has 6 bullish TA indicator(s).

  • CRSP’s TA Score: 6 bullish, 4 bearish.
  • KYTX’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, KYTX is a better buy in the short-term than CRSP.

Price Growth

CRSP (@Biotechnology) experienced а +20.37% price change this week, while KYTX (@Biotechnology) price change was +4.04% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.15%. For the same industry, the average monthly price growth was -16.20%, and the average quarterly price growth was -17.21%.

Reported Earning Dates

CRSP is expected to report earnings on Aug 11, 2025.

KYTX is expected to report earnings on May 20, 2025.

Industries' Descriptions

@Biotechnology (+0.15% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRSP($3.37B) has a higher market cap than KYTX($89M). CRSP YTD gains are higher at: -0.152 vs. KYTX (-44.920). KYTX has higher annual earnings (EBITDA): -108.46M vs. CRSP (-447.31M). CRSP has more cash in the bank: 1.9B vs. KYTX (322M). KYTX has less debt than CRSP: KYTX (9.14M) vs CRSP (224M). CRSP has higher revenues than KYTX: CRSP (35M) vs KYTX (0).
CRSPKYTXCRSP / KYTX
Capitalization3.37B89M3,788%
EBITDA-447.31M-108.46M412%
Gain YTD-0.152-44.9200%
P/E RatioN/AN/A-
Revenue35M0-
Total Cash1.9B322M591%
Total Debt224M9.14M2,452%
FUNDAMENTALS RATINGS
CRSP: Fundamental Ratings
CRSP
OUTLOOK RATING
1..100
55
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
PROFIT vs RISK RATING
1..100
98
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
84
P/E GROWTH RATING
1..100
69
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRSPKYTX
RSI
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
69%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
68%
MACD
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
67%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
72%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 20 days ago
81%
Bullish Trend 11 days ago
79%
Declines
ODDS (%)
Bearish Trend 5 days ago
84%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
67%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JSGTX24.670.46
+1.90%
JHancock U.S. Growth R6
AMRAX6.110.11
+1.83%
American Growth One A
NWZNX16.670.24
+1.46%
Nationwide Loomis All Cap Gr Instl Svc
SAHMX13.350.11
+0.83%
SA International Value
OANBX34.110.26
+0.77%
Oakmark Equity and Income Institutional

KYTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYTX has been loosely correlated with CABA. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if KYTX jumps, then CABA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYTX
1D Price
Change %
KYTX100%
+10.16%
CABA - KYTX
47%
Loosely correlated
+12.84%
IMNM - KYTX
44%
Loosely correlated
+14.52%
CRSP - KYTX
42%
Loosely correlated
+14.71%
ADPT - KYTX
41%
Loosely correlated
+2.78%
PRME - KYTX
41%
Loosely correlated
+13.68%
More